CLDN16 Gene Hypomagnesemia type 3 Genetic Test
Components:
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for CLDN16 Gene Hypomagnesemia type 3 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 3
Test Details:
The CLDN16 gene is associated with a condition called hypomagnesemia type 3. Hypomagnesemia is a disorder characterized by abnormally low levels of magnesium in the blood. The CLDN16 gene provides instructions for producing a protein called claudin-16, which is involved in the reabsorption of magnesium in the kidneys.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the CLDN16 gene. This type of testing can identify specific changes or mutations in the CLDN16 gene that may be causing hypomagnesemia type 3.
By analyzing the CLDN16 gene using NGS, healthcare professionals can determine if there are any genetic variations or mutations that are associated with hypomagnesemia type 3. This information can be helpful in diagnosing the condition and guiding treatment decisions.
It’s important to note that genetic testing for hypomagnesemia type 3 is typically done in conjunction with other diagnostic tests, such as blood tests to measure magnesium levels and kidney function. A healthcare professional will be able to provide more information and guidance on the specific genetic testing process and its implications.
Test Name | CLDN16 Gene Hypomagnesemia type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CLDN16 Gene Hypomagnesemia type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 3 |
Test Details |
The CLDN16 gene is associated with a condition called hypomagnesemia type 3. Hypomagnesemia is a disorder characterized by abnormally low levels of magnesium in the blood. The CLDN16 gene provides instructions for producing a protein called claudin-16, which is involved in the reabsorption of magnesium in the kidneys. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the CLDN16 gene. This type of testing can identify specific changes or mutations in the CLDN16 gene that may be causing hypomagnesemia type 3. By analyzing the CLDN16 gene using NGS, healthcare professionals can determine if there are any genetic variations or mutations that are associated with hypomagnesemia type 3. This information can be helpful in diagnosing the condition and guiding treatment decisions. It’s important to note that genetic testing for hypomagnesemia type 3 is typically done in conjunction with other diagnostic tests, such as blood tests to measure magnesium levels and kidney function. A healthcare professional will be able to provide more information and guidance on the specific genetic testing process and its implications. |